AdaptHealth (AHCO) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
18 Jun, 2026Opening remarks and agenda
The meeting was called to order by the CEO, who welcomed stockholders and explained the virtual format to maximize participation.
Attendees were informed about the opportunity to submit questions during the meeting, with a Q&A session scheduled after formal business.
The record date for voting was April 24, 2026, and proxy materials were distributed on or about April 28, 2026.
Corporate governance
Quorum was established with sufficient shares present or represented by proxy.
Lou Larson was appointed as Inspector of Elections and took an oath of office.
Board and executive committee updates
Nine directors were nominated for election to serve a one-year term expiring at the 2027 annual meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from AdaptHealth
- Major new capitated contract boosts growth, with margins set to improve through 2026.AHCO
Bank of America Global Healthcare Conference 202612 May 2026 - Net revenue up 5.4% to $819.8M, but margin and net loss worsened amid higher costs.AHCO
Q1 20265 May 2026 - Annual meeting covers director elections, auditor ratification, and say-on-pay, with strong governance.AHCO
Proxy filing28 Apr 2026 - Record operational gains and exclusive payer contracts drive growth and portfolio focus.AHCO
Leerink Global Healthcare Conference 20269 Mar 2026 - Expanding market share and operational scale in sleep and respiratory care, with strong contract growth.AHCO
J.P. Morgan 2026 Global Leveraged Finance Conference3 Mar 2026 - Record patient growth and a major contract drove 2025, but a $128M impairment led to a net loss.AHCO
Q4 202524 Feb 2026 - Q2 revenue up 1.6%, net income up 39%, strong cash flow, and ongoing legal challenges.AHCO
Q2 20242 Feb 2026 - Five-point plan drives growth as respiratory and sleep outperform, while GLP-1 use rises among new CPAP patients.AHCO
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Q3 2024 returned to profitability with $22.9M net income and improved cash flow.AHCO
Q3 202416 Jan 2026